No insider purchase over the last 90 days. The latest was filed 13 May 2026.
LS belongs to the Chemicals sector. Filings by its managers are published through DART (FSS). Between 18 October 2025 and 18 October 2026, 6 insiders published 9 filings.
Both sides are active: 2 purchases worth €462.8M and 2 sales worth €882k, from 2 insiders and 2 insiders respectively. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €462.8M by 삼성자산운용, published on 13 May 2026, equal to 8.3% of the market capitalisation.
With 9 filings in twelve months, the company is more active than the median of 7 filings across the 2,648 companies we follow on the same exchange. Our records for LS go back to 2021, with 5 purchases and 9 sales on the open market in total.
The last insider purchase was made public on 13 May 2026, 158 days ago. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate LS Strong Buy (bullish), based on 8 analysts. Average price target: ₩535,250.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 92 declarations
LS is a company operating in the chemicals and materials sector, listed on the XKRX market.
Purchases our model currently ranks for the recommendations list.
All recommendations